Cadence is a bank holding company. The company is engaged in commercial lending to middle-market customers and provide a range of commercial loans to middle-market commercial businesses, individuals and business owners. The company's loan portfolio includes commercial and industrial loans, residential real estate loans, commercial real estate loans and other consumer loans. The company also provides its customers a variety of deposit products, including checking accounts, savings accounts, money market accounts and other deposit accounts, through multiple channels, including its network of full-service branches, drive-thru branches, ATMs, ITMs, and its online, mobile and telephone banking platforms.

Enterprise Products Partners is a provider of midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals and refined products. The company's midstream energy operations include: natural gas gathering, treating, processing, transportation and storage; NGL transportation, fractionation, storage, and export and import terminals; crude oil gathering, transportation, storage, and export and import terminals; petrochemical and refined products transportation, storage, export and import terminals, and related services; and a marine transportation business that operates primarily on the U.S. inland and Intracoastal Waterway systems.

FedEx provides transportation, e-commerce and business services through companies under the FedEx brand. These companies are included in the following segments: Federal Express Corporation, including TNT Express B.V., is an express transportation company; FedEx Ground Package System, Inc., which is a provider of small-package ground delivery services; FedEx Freight Corporation, which is a provider of less-than-truckload freight services; and FedEx Corporate Services, Inc., which provides sales, marketing, information technology, communications, customer service, technical support, billing and collections services, and certain back-office functions.

Jernigan Capital is a commercial real estate company that invests primarily in new or recently-constructed and opened self-storage facilities located in dense urban submarkets within U.S. metropolitan statistical areas (MSAs). The company conducts its investment activities through its operating company, Jernigan Capital Operating Company, LLC. The company focuses on originating the following types of investments: Development Property Investments, which finances ground-up construction of self-storage facilities or self-storage conversion or redevelopment opportunities within the MSA; Wholly-Owned Property Investments; and Bridge Investments.

Marrone Bio Innovations makes bio-based pest management and plant health products. Bio-based products are comprised of naturally occurring microorganisms, such as bacteria and fungi, and plant extracts. The company primarily sells its products to the crop protection market and also have one plant health product, Haven, that reduces plant stress in drought and intense sunlight. The company's product lines are Regalia, for controlling plant disease and increasing plant health, Grandevo and Venerate, for insect and mite control, Majestene and its turf and ornamentals counterpart brand Zelto, for nematode control and Stargus and its row crop counterpart brand Amplitude, for downy mildew and white mold control.

MEI Pharma is a late-stage pharmaceutical company focused on development and oncology capabilities to identify and develop therapies for the treatment of cancer. The company has four clinical-stage development programs with approaches to inhibiting cancer, including epigenetics, cell signalling and cancer metabolism: ME-401, an oral phosphatidylinositol 3-kinase delta inhibitor; Voruciclib, an oral cyclin-dependent kinase inhibitor; ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex; and Pracinostat, an oral histone deacetylase inhibitor being evaluated in a pivotal Phase 3 global registration clinical trial for the treatment of adults with acute myeloid leukemia.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Pope Resources is engaged primarily in managing timber resources on its own properties as well as those owned by others. The company operates in four business segments: Partnership Timber, and Funds Timber, which both consist of growing, managing, harvesting, and marketing timber; Timberland Investment Management, which is engaged in organizing and managing private equity timber funds using capital invested by third parties and the company; and Real Estate, which is focused on a portfolio in the west Puget Sound region of Washington, most of which are legacy timberlands that have become suitable as development property owing to the expansion of the Puget Sound metropolitan and suburban areas.

RiceBran Technologies is an ingredient company serving food, animal nutrition and specialty markets focused on processing and marketing of healthy, natural and nutrient dense products derived from raw rice bran, an underutilized by-product of the rice milling industry. The company converts raw rice bran into various products including: stabilized rice bran (SRB); RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and its family of ProRyza products, which includes derivatives composed of protein and protein/fiber blends.

Schmitt Industries is engaged in providing precision test, measurement and process control products. The company has the following segments: Balancer, which designs, manufactures and sells computer-controlled vibration detection, balancing and process control systems for the worldwide machine tool industry, particularly for grinding machines; and Measurement, which through its wholly owned subsidiary, Schmitt Measurement Systems, Inc., manufacturers and sells products in two primary product lines, Acuity and Xact. Acuity sells products, solutions and services that includes laser and white light sensor distance. Xact includes satellite focused remote tank monitoring products.

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.